Skip to main content
Glama

Itis

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already establish read-only, open-world, idempotent, non-destructive behavior. The description goes well beyond that by disclosing graceful degradation of LEI/FIGI enrichment, the cascading internal lookups, the explicit `unresolved` field behavior, source labeling, and the `figi_candidates` ambiguity handling. This gives an agent realistic expectations for fallback behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but nearly every sentence carries operational detail: examples, successor guidance, supported types, edge-case behavior, and fallback semantics. It is front-loaded with the usage trigger. The density is high enough that it is slightly overwhelming, but no part is filler.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description explains the return contract well: identifiers, source labels, unresolved entries, candidate lists for ambiguity, and degraded modes. It also covers all input forms and entity domains. Nothing critical to selecting or invoking the tool correctly appears missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, and the description still adds substantial meaning beyond it: exact input examples for ticker/CIK/ISIN/name, drug brand/generic examples, the instruction to pass only the entity name, and the bond-specific caveat about trailing security-class words. This materially reduces misparameterization.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user-phrase examples and a precise verb: 'resolve a user-spoken NAME to the canonical/official identifiers.' It clearly distinguishes itself from siblings like entity_profile or compare_entities by framing itself as the identity-resolution front door, and it enumerates exactly which entity types it covers.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives explicit guidance: 'Use FIRST whenever you have a name but need an ID,' and it specifies supported types (company, drug) and acceptable inputs. It does not name sibling tools as alternatives or state when not to use it, but the examples and supported-type list make the intended invocation context clear.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Itis toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Several tools occupy overlapping roles: ask_pipeworx and ask_pipeworx_beta are currently identical, ask_pipeworx_grounded/deep_research/validate_claim all provide grounded answering, and bet_research/polymarket_edges/polymarket_arbitrage all surface betting opportunities. The descriptions are detailed, but the boundaries between routers and research modes are fuzzy enough that an agent could easily select the wrong one. The taxonomy, memory, and subscription clusters are distinct, but they are drowned out by the overlapping meta-tools.

Naming Consistency3/5

All names use snake_case, which provides some visual consistency, but the verb_noun pattern is not consistently applied: search_taxa/get_hierarchy are clean verb_noun, while deep_research, entity_profile, polymarket_edges, and bet_research are noun-ish or reversed patterns. There is good family-level consistency within ask_pipeworx_* and polymarket_*, but the overall set mixes conventions and requires reading descriptions to infer what each tool does.

Tool Count2/5

34 tools is well over the 25-tool threshold and reflects a sprawling multi-domain server spanning taxonomy, structured-data lookup, prediction markets, subscriptions, memory, and AI visibility. Each cluster may be individually reasonable, but as a single MCP surface it is too heavy and forces agents to filter through many irrelevant tools.

Completeness4/5

For the broad data-research and prediction-market purpose, the surface is fairly complete: it covers routing, grounded answers, deep multi-source research, entity profiles, comparisons, claim validation, entity resolution, subscriptions, alerts, memory, and market edge/fill checks. Minor gaps exist—no direct web-search tool, the beta router adds no current behavior, and some patent endpoints soft-fail—but agents can generally work around them.

Resources